Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1975 1
1982 1
1983 1
1985 1
1986 1
1990 1
1992 2
1994 1
1997 1
1999 1
2000 1
2001 2
2002 6
2003 8
2004 1
2005 7
2006 3
2007 1
2010 1
2013 1
2014 4
2015 4
2017 3
2018 4
2019 5
2020 4
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Romosozumab and antiresorptive treatment: the importance of treatment sequence.
Cosman F, Kendler DL, Langdahl BL, Leder BZ, Lewiecki EM, Miyauchi A, Rojeski M, McDermott M, Oates MK, Milmont CE, Libanati C, Ferrari S. Cosman F, et al. Osteoporos Int. 2022 Jun;33(6):1243-1256. doi: 10.1007/s00198-021-06174-0. Epub 2022 Feb 15. Osteoporos Int. 2022. PMID: 35165774 Free PMC article.
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.
Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, Cabrejo L, Cha JK, Ducrocq G, Giroud M, Guidoux C, Hobeanu C, Kim YJ, Lapergue B, Lavallée PC, Lee BC, Lee KB, Leys D, Mahagne MH, Meseguer E, Nighoghossian N, Pico F, Samson Y, Sibon I, Steg PG, Sung SM, Touboul PJ, Touzé E, Varenne O, Vicaut É, Yelles N, Bruckert E; Treat Stroke to Target Investigators. Amarenco P, et al. N Engl J Med. 2020 Jan 2;382(1):9. doi: 10.1056/NEJMoa1910355. Epub 2019 Nov 18. N Engl J Med. 2020. PMID: 31738483 Clinical Trial.
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O'Donnell MJ, De Vries Basson MM, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ; NAVIGATE ESUS Investigators. Hart RG, et al. N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16. N Engl J Med. 2018. PMID: 29766772 Free article. Clinical Trial.
Genetic Risk Score for Intracranial Aneurysms: Prediction of Subarachnoid Hemorrhage and Role in Clinical Heterogeneity.
Bakker MK, Kanning JP, Abraham G, Martinsen AE, Winsvold BS, Zwart JA, Bourcier R, Sawada T, Koido M, Kamatani Y, Morel S, Amouyel P, Debette S, Bijlenga P, Berrandou T, Ganesh SK, Bouatia-Naji N, Jones G, Bown M, Rinkel GJE, Veldink JH, Ruigrok YM; HUNT All-In Stroke, CADISP group, International Consortium for Blood Pressure, International Headache Genetics Consortium, International Stroke Genetics Consortium (ISGC) Intracranial Aneurysm Working Group. Bakker MK, et al. Stroke. 2023 Mar;54(3):810-818. doi: 10.1161/STROKEAHA.122.040715. Epub 2023 Jan 19. Stroke. 2023. PMID: 36655558 Free PMC article.
Clinical Characteristics and Outcomes Among Travelers With Severe Dengue : A GeoSentinel Analysis.
Huits R, Angelo KM, Amatya B, Barkati S, Barnett ED, Bottieau E, Emetulu H, Epelboin L, Eperon G, Medebb L, Gobbi F, Grobusch MP, Itani O, Jordan S, Kelly P, Leder K, Díaz-Menéndez M, Okumura N, Rizwan A, Rothe C, Saio M, Waggoner J, Yoshimura Y, Libman M, Hamer DH, Schwartz E. Huits R, et al. Ann Intern Med. 2023 Jul;176(7):940-948. doi: 10.7326/M23-0721. Epub 2023 Jun 20. Ann Intern Med. 2023. PMID: 37335991 Free PMC article.
Observation of B-->K*l+l-.
Ishikawa A, Abe K, Abe K, Abe T, Adachi I, Ahn BS, Aihara H, Akai K, Akatsu M, Akemoto M, Asano Y, Aso T, Aulchenko V, Aushev T, Bakich AM, Ban Y, Bay A, Bizjak I, Bondar A, Bozek A, Bracko M, Browder TE, Chang P, Chao Y, Chen KF, Cheon BG, Chistov R, Choi SK, Choi Y, Choi YK, Chuvikov A, Danilov M, Dong LY, Drutskoy A, Eidelman S, Eiges V, Enari Y, Flanagan J, Fukunaga C, Funakoshi Y, Furukawa K, Gabyshev N, Garmash A, Gershon T, Golob B, Guo R, Haba J, Hagner C, Handa F, Hayashii H, Hazumi M, Hinz L, Hokuue T, Hoshi Y, Hou WS, Hsiung YB, Huang HC, Iijima T, Inami K, Itoh R, Iwasaki H, Iwasaki M, Iwasaki Y, Kang JH, Kang JS, Katayama N, Kawai H, Kawasaki T, Kichimi H, Kikutani E, Kim HJ, Kim H, Kim JH, Kim SK, Kinoshita K, Koppenburg P, Korpar S, Krizan P, Krokovny P, Kuzmin A, Kwon YJ, Lange JS, Leder G, Lee SH, Lesiak T, Li J, Limosani A, Lin SW, Liventsev D, MacNaughton J, Majumder G, Mandl F, Masuzawa M, Matsumoto T, Matyja A, Michizono S, Mimashi T, Mitaroff W, Miyabayashi K, Miyake H, Miyata H, Mohapatra D, Mori T, Nagamine T, Nagasaka Y, Nakadaira T, Nakamura TT, Nakao M, Nakazawa H, Natkaniec Z, Nishida S, Nitoh O, Nozaki T, Ogawa S, Ogawa Y, Ohmi K, Ohnishi Y, Ohshima T,… See abstract for full author list ➔ Ishikawa A, et al. Phys Rev Lett. 2003 Dec 31;91(26 Pt 1):261601. doi: 10.1103/PhysRevLett.91.261601. Epub 2003 Dec 24. Phys Rev Lett. 2003. PMID: 14754037
We report the observation of the flavor-changing neutral current decay B-->K(*)l(+)l(-) and an im-proved measurement of the decay B-->Kl(+)l(-), where l represents an electron or a muon, with a data sample of 140 fb(-1) accumulated at the Upsilon(4S) resonance with t …
We report the observation of the flavor-changing neutral current decay B-->K(*)l(+)l(-) and an im-proved measurement of the decay …
Intracranial Hemorrhage in the TST Trial.
Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Lavallée PC, Lee BC, Mahagne MH, Meseguer E, Nighoghossian N, Steg PG, Vicaut É, Bruckert E; Treat Stroke to Target Investigators*. Amarenco P, et al. Stroke. 2022 Feb;53(2):457-462. doi: 10.1161/STROKEAHA.121.035846. Epub 2021 Dec 29. Stroke. 2022. PMID: 34963300 Clinical Trial.
Delayed Denosumab Injections and Fracture Risk Among Patients With Osteoporosis : A Population-Based Cohort Study.
Lyu H, Yoshida K, Zhao SS, Wei J, Zeng C, Tedeschi SK, Leder BZ, Lei G, Tang P, Solomon DH. Lyu H, et al. Ann Intern Med. 2020 Oct 6;173(7):516-526. doi: 10.7326/M20-0882. Epub 2020 Jul 28. Ann Intern Med. 2020. PMID: 32716706
DESIGN: Population-based cohort study. SETTING: The Health Improvement Network U.K. primary care database, 2010 to 2019. PATIENTS: Persons aged 45 years or older who initiated denosumab therapy for osteoporosis. ...
DESIGN: Population-based cohort study. SETTING: The Health Improvement Network U.K. primary care database, 2010 to 2019. PATIENTS: Pe …
[Lutz-Dietrich Leder: 12.02.1933-05.06.2013].
Donhuijsen K. Donhuijsen K. Pathologe. 2014 Nov;35 Suppl 2:313-4. doi: 10.1007/s00292-014-1969-0. Pathologe. 2014. PMID: 25348117 German. No abstract available.
72 results